Episode Details
Back to EpisodesCould GLP-1 receptor agonists reduce the risk of blood cancers in type 2 diabetes patients?
Episode 484
Published 1 year, 5 months ago
Description
A study suggests GLP-1 receptor agonists may reduce hematologic cancer risk in type 2 diabetes patients by 54% compared to insulin. Two individuals have achieved functional HIV cures through stem cell transplants, offering insights into cure strategies. Additionally, women with dense breasts face double the risk of breast cancer and reduced mammogram accuracy, supporting FDA regulations for breast density notifications and additional screening methods.